CD146 expression in T3 tumors (49.0%) was higher than that in T2 tumors (33.3%), and the levels of expression increased with an increase in tumor size (33.3, 45.9, 63.6%), although the results were not statistically significant. This evidence concerns the gene MCAM and neoplasm.